Department of Psychiatry & Psychology Grand Rounds/#47032016
Diabetes, Hypertension, and Lipids: Cases for Psychiatrists
Christopher M. Wittich, MD, PharmD
Introduction
Dr. Wittich received his undergrad in Pharm D from the University of Iowa. He graduated with honors in Pharmacy and Highest Distinction. He then attended Mayo Medical School and did his Internal Medicine Residency at the Mayo School of Graduate Medical Education where he was Chief Medical Resident for one additional year. Presently, Dr. Wittich is the Practice Chair for General Internal Medicine and Associate Program Director of the Internal Medicine Residency Program. Dr. Wittich has research interests in graduate medical education and continuous professional development.
Learning Objectives
List contraindications to medications for diabetes
State when to start a statin based on ASCVD risk score
Describe blood pressure treatment goals based on comorbidities
Live webcast available at: http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live. MedHub will be implemented for all post presentation surveys. Your name and e-mail are not linked to your evaluation. Identifiers are tracked separately for attendance records only. To document your attendance, please send an email to rstpsychgr@mayo.edu. The badge reader should continue to be utilized for Gonda and Sister Helen Hayes locations.
Credit Statements
Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mayo Clinic College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Archived webcast available at: Psychiatry & Psychology Video Library
Industry Acknowledgment (if applicable): None.
Disclosure Summary
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Professional Development), must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.
Listed below are individuals with control of the content of this program who have disclosed…
Relevant financial relationship(s) with industry:
None
No relevant financial relationship(s) with industry:
Brian Palmer, M.D., Michael Bostwick, M.D., Karen Grothe, Ph.D., Lois Krahn, M.D., Jarrod Leffler, Ph.D., Larissa Loukianova, M.D., Mary Machulda, M.D., Patricia Maus, M.D., Amber Pearson, Jeffrey Staab, M.D., Cosima Swintak, M.D., Kristin Vickers Douglas, Ph.D., Cynthia Harbeck-Weber, Ph.D., Michael Zaccariello, Ph.D., Georgina Rink
Christopher Wittich, MD, PharmD
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None
Questions regarding this program can be directed to rstpsychgr@mayo.edu

Facebook
X
LinkedIn
Forward